SUVRETTA CAPITAL MANAGEMENT, LLC purchased 1.6% of their position (16.50K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $211.7K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 4/2/2025ACC: 0000899140-25-000486
10% Owner
Since Apr 2024
+16.50K
Net shares
Net buyer
$211.7K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
16.50K acquired
Non-Derivative Transactions4
Common stock, par value $0.0001 per share
Indirect
Shares
+9.50K
Price / share
$12.63
Trade value
$120.02K
% of position
0.1%
3/31/2025
8.79M→8.80M
Common stock, par value $0.0001 per share
Indirect
Shares
+1.27K
Price / share
$12.63
Trade value
$16K
% of position
0.1%
3/31/2025
1.07M→1.07M
Common stock, par value $0.0001 per share
Indirect
Shares
+5.06K
Price / share
$13.22
Trade value
$66.85K
% of position
0.1%
3/31/2025
8.80M→8.81M
Common stock, par value $0.0001 per share
Indirect
Shares
+670.00
Price / share
$13.22
Trade value
$8.86K
% of position
0.1%
3/31/2025
1.07M→1.07M
Total
Net shares
+16.50K
Net value
$211.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 3/31/2025 | P · Purchase | +9.50K | $12.63 | $120.02K | 0.1% | 8.79M | 8.80M |
| Common stock, par value $0.0001 per share Indirect | 3/31/2025 | P · Purchase | +1.27K | $12.63 | $16K | 0.1% | 1.07M | 1.07M |
| Common stock, par value $0.0001 per share Indirect | 3/31/2025 | P · Purchase | +5.06K | $13.22 | $66.85K | 0.1% | 8.80M | 8.81M |
| Common stock, par value $0.0001 per share Indirect | 3/31/2025 | P · Purchase | +670.00 | $13.22 | $8.86K | 0.1% | 1.07M | 1.07M |
| Total | +16.50K | $211.74K | ||||||
Derivative Transactions0
No derivative transactions reported